Table 4 FMA-UE and improvement rates for each participant at baseline (T0), post-assessment (T1) and follow-up (T2)
FMA-UE | P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 | P10 |
|---|---|---|---|---|---|---|---|---|---|---|
Baseline (T0) | 36 | 47 | 55 | 17 | 21 | 37 | 57 | 18 | 50 | 54 |
Post-treatment (T1) | 33 | 54 | 55 | 24 | 23 | 38 | 58 | 17 | 51 | 55 |
Follow-up (T2) | 30 | 54 | 58 | 26 | 23 | 39 | 59 | 19 | 52 | 61 |
Improvement rate at T1 | −10% | 37% | 0% | 14% | 4% | 3% | 11% | −2% | 6% | 8% |
Improvement rate at T2 | −20% | 37% | 27% | 18% | 4% | 7% | 22% | 2% | 13% | 58% |